Compile Data Set for Download or QSAR
maximum 50k data
Found 69 Enz. Inhib. hit(s) with all data for entry = 50033385
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032651(1-((1S,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-y...)
Affinity DataKi:  4.60nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344250(CHEMBL1779003 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  12nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344232(1-cyclopropyl-N-((6-(4-fluoro-2-methoxyphenyl)pyra...)
Affinity DataKi:  27nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344251(CHEMBL1779004 | N-((4'-fluoro-2'-methoxybiphenyl-3...)
Affinity DataKi:  48nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344233(CHEMBL1778866 | N-((6-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  53nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344234(CHEMBL1778867 | N-((6-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  54nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344252(CHEMBL1779005 | N-((6-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  66nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344259(CHEMBL1779012 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  80nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344254(CHEMBL1779007 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  112nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344260(CHEMBL1779013 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  116nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344241(CHEMBL1778994 | N-((6-(2,3-difluorophenyl)pyrazin-...)
Affinity DataKi:  186nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344235(CHEMBL1778868 | N-((6-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  214nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344236(CHEMBL1778869 | N-((6-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  217nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344237(CHEMBL1778870 | N-((6-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  255nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344255(CHEMBL1779008 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  266nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344262(CHEMBL1779015 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  268nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344264(CHEMBL1779016 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  340nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344242(1-cyclopropyl-N-((6-(2,3-difluorophenyl)pyrazin-2-...)
Affinity DataKi:  341nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344265(3-((5-(4-fluoro-2-methoxyphenyl)pyridin-3-yl)methy...)
Affinity DataKi:  420nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344238(CHEMBL1778991 | N-((6-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  429nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344256(3-(4-fluoro-2-methoxyphenyl)-5-(pyrrolidin-2-yl)py...)
Affinity DataKi:  440nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344261(CHEMBL1779014 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  450nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344257(CHEMBL1779010 | N-benzyl-5-(4-fluoro-2-methoxyphen...)
Affinity DataKi:  457nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344266(CHEMBL1779018 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  468nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344267(CHEMBL1779019 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  595nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344244(1-cyclopropyl-N-((6-(2-fluoro-3-methoxyphenyl)pyra...)
Affinity DataKi:  602nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344239((S)-1-(6-(4-fluoro-2-methoxyphenyl)pyrazin-2-yl)-N...)
Affinity DataKi:  610nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344258(5-(4-fluoro-2-methoxyphenyl)-N-(tetrahydro-2H-pyra...)
Affinity DataKi:  705nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344268(CHEMBL1779020 | ethyl 2-((5-(4-fluoro-2-methoxyphe...)
Affinity DataKi:  778nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344246(3-(6-((cyclopentylamino)methyl)pyrazin-2-yl)benzon...)
Affinity DataKi:  1.55E+3nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344247(4-(6-((cyclopentylamino)methyl)pyrazin-2-yl)benzon...)
Affinity DataKi:  1.57E+3nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344248(CHEMBL1779001 | N-((6-(2,4-dimethoxyphenyl)pyrazin...)
Affinity DataKi:  1.69E+3nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344243(CHEMBL1778996 | N-((6-(2,3-difluorophenyl)pyrazin-...)
Affinity DataKi:  2.98E+3nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344240(1-(6-(4-fluoro-2-methoxyphenyl)pyrazin-2-yl)-N-(py...)
Affinity DataKi:  3.57E+3nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344245(CHEMBL1778998 | N-((6-(2-fluoro-3-methoxyphenyl)py...)
Affinity DataKi:  5.70E+3nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344253(CHEMBL1779006 | N-((2-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataKi:  8.90E+3nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rattus norvegicus (Rat))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344249(CHEMBL1779002 | N-(3-(6-((cyclopentylamino)methyl)...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]CP101606 from NR2B in rat brain minus cerebellum membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344263((+)-1-methyl-16-azatetracyclo[7.6.1.02,7.010,15]he...)
Affinity DataIC50:  29nMAssay Description:Antagonist activity at NR2A transfected in oocytesMore data for this Ligand-Target Pair
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032651(1-((1S,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-y...)
Affinity DataIC50:  74nMAssay Description:Antagonist activity at human NR2B expressed in HEK293 cells assessed as glutamate-induced changes in intracellular calcium concentrationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344250(CHEMBL1779003 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataIC50:  230nMAssay Description:Iinhibition of CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344259(CHEMBL1779012 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataIC50:  262nMAssay Description:Antagonist activity at human NR2B expressed in HEK293 cells assessed as glutamate-induced changes in intracellular calcium concentrationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344232(1-cyclopropyl-N-((6-(4-fluoro-2-methoxyphenyl)pyra...)
Affinity DataIC50:  380nMAssay Description:Iinhibition of CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344232(1-cyclopropyl-N-((6-(4-fluoro-2-methoxyphenyl)pyra...)
Affinity DataIC50:  508nMAssay Description:Antagonist activity at human NR2B expressed in HEK293 cells assessed as glutamate-induced changes in intracellular calcium concentrationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344260(CHEMBL1779013 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataIC50:  673nMAssay Description:Antagonist activity at human NR2B expressed in HEK293 cells assessed as glutamate-induced changes in intracellular calcium concentrationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344250(CHEMBL1779003 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataIC50:  770nMAssay Description:Antagonist activity at human NR2B expressed in HEK293 cells assessed as glutamate-induced changes in intracellular calcium concentrationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344250(CHEMBL1779003 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataIC50:  1.89E+3nMAssay Description:Inhibition of human ERG expressed in CHOK1 cells electrophysiology studyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344232(1-cyclopropyl-N-((6-(4-fluoro-2-methoxyphenyl)pyra...)
Affinity DataIC50:  1.89E+3nMAssay Description:Inhibition of human ERG expressed in CHOK1 cells electrophysiology studyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344251(CHEMBL1779004 | N-((4'-fluoro-2'-methoxybiphenyl-3...)
Affinity DataIC50:  2.15E+3nMAssay Description:Inhibition of human ERG expressed in CHOK1 cells electrophysiology studyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344254(CHEMBL1779007 | N-((5-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataIC50:  2.18E+3nMAssay Description:Inhibition of human ERG expressed in CHOK1 cells electrophysiology studyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344253(CHEMBL1779006 | N-((2-(4-fluoro-2-methoxyphenyl)py...)
Affinity DataIC50:  3.85E+3nMAssay Description:Inhibition of human ERG expressed in CHOK1 cells electrophysiology studyMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 69 total ) | Next | Last >>
Jump to: